20 research outputs found
Engineered metalloproteins as contrast sensors for molecular fMRI
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Biological Engineering, February 2010.Cataloged from PDF version of thesis.Includes bibliographical references (p. 86-99).Functional brain imaging technologies seek to expand our understanding of intact neural systems. Present day functional MRI (fMRI) measures the delayed hemodynamic response that is indirectly associated with neural activity. To study underlying molecular systems noninvasively but precisely, tools must be developed to modulate MRI contrast as a function of discrete molecular events within pathways of interest. In optical imaging modalities, genetically encoded sensors based on fluorescent proteins have provided an engineerable platform on which to optimize desirable device characteristics by exploiting the tools of molecular biology and protein biochemistry. Analogously, we seek to build genetically encodable sensors based on engineered metalloproteins whose effects on MRI contrast are regulated by specific biochemical interactions. In this work, we present two technological advancements toward realizing fMRI contrast sensors for molecular neuroimaging. First, a genetically encodable sensor for free calcium is described, consisting of a novel ferritin-based device that reversibly enhances NMR transverse relaxation times (T2) by Ca - dependent crosslinking. Second, we show that the T1 contrast effect of a recently proposed family of cytochrome P450-based MRI sensors can be significantly enhanced by substitution of the protein's native heme with a high spin manganese porphyrin.by Victor S. Lelyveld.Ph.D
Magnetic nanosensors optimized for rapid and reversible self-assembly
Magnetic nanoparticle-based sensors for MRI have been accelerated to a timescale of seconds using densely-functionalized particles of small size. Parameters that increase response rates also result in large nuclear magnetic relaxation rate and light scattering changes, allowing signals to be detected almost immediately after changes in calcium concentration.United States. National Institutes of Health (DP2-OD2114)United States. National Institutes of Health (R01-DA28299)United States. National Institutes of Health (R01-NS76462
Recommended from our members
Pinpointing RNA-Protein Cross-Links with Site-Specific Stable Isotope-Labeled Oligonucleotides
High affinity RNA-protein interactions are critical to cellular function, but directly identifying the determinants of binding within these complexes is often difficult. Here, we introduce a stable isotope mass labeling technique to assign specific interacting nucleotides in an oligonucleotide-protein complex by photo-cross-linking. The method relies on generating site-specific oxygen-18-labeled phosphodiester linkages in oligonucleotides, such that covalent peptide-oligonucleotide cross-link sites arising from ultraviolet irradiation can be assigned to specific sequence positions in both RNA and protein simultaneously by mass spectrometry. Using Lin28A and a let-7 pre-element RNA, we demonstrate that mass labeling permits unambiguous identification of the cross-linked sequence positions in the RNA-protein complex
Structure-Guided Directed Evolution of Highly Selective P450-Based Magnetic Resonance Imaging Sensors for Dopamine and Serotonin
New tools that allow dynamic visualization of molecular neural events are important for studying the basis of brain activity and disease. Sensors that permit ligand-sensitive magnetic resonance imaging (MRI) are useful reagents due to the noninvasive nature and good temporal and spatial resolution of MR methods. Paramagnetic metalloproteins can be effective MRI sensors due to the selectivity imparted by the protein active site and the ability to tune protein properties using techniques such as directed evolution. Here, we show that structure-guided directed evolution of the active site of the cytochrome P450‐BM3 heme domain produces highly selective MRI probes with submicromolar affinities for small molecules. We report a new, high‐affinity dopamine sensor as well as the first MRI reporter for serotonin, with which we demonstrate quantification of neurotransmitter release in vitro. We also present a detailed structural analysis of evolved cytochrome P450‐BM3 heme domain lineages to systematically dissect the molecular basis of neurotransmitter binding affinity, selectivity, and enhanced MRI contrast activity in these engineered proteins
Metal-substituted protein MRI contrast agents engineered for enhanced relaxivity and ligand sensitivity
Engineered metalloproteins constitute a flexible new class of analyte-sensitive molecular imaging agents detectable by magnetic resonance imaging (MRI), but their contrast effects are generally weaker than synthetic agents. To augment the proton relaxivity of agents derived from the heme domain of cytochrome P450 BM3 (BM3h), we formed manganese(III)-containing proteins that have higher electron spin than their native ferric iron counterparts. Metal substitution was achieved by coexpressing BM3h variants with the bacterial heme transporter ChuA in Escherichia coli and supplementing the growth medium with Mn3+-protoporphyrin IX. Manganic BM3h variants exhibited up to 2.6-fold higher T1 relaxivities relative to native BM3h at 4.7 T. Application of ChuA-mediated porphyrin substitution to a collection of thermostable chimeric P450 domains resulted in a stable, high-relaxivity BM3h derivative displaying a 63% relaxivity change upon binding of arachidonic acid, a natural ligand for the P450 enzyme and an important component of biological signaling pathways. This work demonstrates that protein-based MRI sensors with robust ligand sensitivity may be created with ease by including metal substitution among the toolkit of methods available to the protein engineer.National Institutes of Health (U.S.) (NIH Grant R01-DA28299 )National Institutes of Health (U.S.) (NIH NRSA Fellowship (Award F32-GM087102))California Institute of Technology (Caltech Jacobs Grant
Structural interpretation of the effects of threo-nucleotides on nonenzymatic template-directed polymerization
The prebiotic synthesis of ribonucleotides is likely to have been accompanied by the synthesis of noncanonical nucleotides including the threo-nucleotide building blocks of TNA. Here, we examine the ability of activated threo-nucleotides to participate in nonenzymatic template-directed polymerization. We find that primer extension by multiple sequential threo-nucleotide monomers is strongly disfavored relative to ribo-nucleotides. Kinetic, NMR and crystallographic studies suggest that this is due in part to the slow formation of the imidazolium-bridged TNA dinucleotide intermediate in primer extension, and in part because of the greater distance between the attacking RNA primer 3'-hydroxyl and the phosphate of the incoming threo-nucleotide intermediate. Even a single activated threo-nucleotide in the presence of an activated downstream RNA oligonucleotide is added to the primer 10-fold more slowly than an activated ribonucleotide. In contrast, a single activated threo-nucleotide at the end of an RNA primer or in an RNA template results in only a modest decrease in the rate of primer extension, consistent with the minor and local structural distortions revealed by crystal structures. Our results are consistent with a model in which heterogeneous primordial oligonucleotides would, through cycles of replication, have given rise to increasingly homogeneous RNA strands
Molecular fMRI of Serotonin Transport
Reuptake of neurotransmitters from the brain interstitium shapes chemical signaling processes and is disrupted in several pathologies. Serotonin reuptake in particular is important for mood regulation and is inhibited by first-line drugs for treatment of depression. Here we introduce a molecular-level fMRI technique for micron-scale mapping of serotonin transport in live animals. Intracranial injection of an MRI-detectable serotonin sensor complexed with serotonin, together with serial imaging and compartmental analysis, permits neurotransmitter transport to be quantified as serotonin dissociates from the probe. Application of this strategy to much of the striatum and surrounding areas reveals widespread nonsaturating serotonin removal with maximal rates in the lateral septum. The serotonin reuptake inhibitor fluoxetine selectively suppresses serotonin removal in septal subregions, whereas both fluoxetine and a dopamine transporter blocker depress reuptake in striatum. These results highlight promiscuous pharmacological influences on the serotonergic system and demonstrate the utility of molecular fMRI for characterization of neurochemical dynamics.
Keywords
antidepressant; reuptake transporter; SSRI; molecular imaging; serotonin; fMRI; magnetic resonance imaging; in vivo; striatum; dopamineNational Institutes of Health (U.S.) (Grant R01 DA028299)National Institutes of Health (U.S.) (Grant R01 DA038642)National Institutes of Health (U.S.) (Grant R01 NS076462
Experimental and Computational Evidence for a Loose Transition State in Phosphoroimidazolide Hydrolysis
Phosphoroimidazolides
play a critical role in several enzymatic
phosphoryl transfer reactions and have been studied extensively as
activated monomers for nonenzymatic nucleic acid replication, but
the detailed mechanisms of these phosphoryl transfer reactions remain
elusive. Some aspects of the mechanism can be deduced by studying
the hydrolysis reaction, a simpler system that is amenable to a thorough
mechanistic treatment. Here we characterize the transition state of
phosphoroimidazolide hydrolysis by kinetic isotope effect
(KIE) and linear free energy relationship (LFER) measurements, and
theoretical calculations. The KIE and LFER observations are best explained
by calculated loose transition structures with extensive scissile
bond cleavage. These three-dimensional models of the transition state
provide the basis for future mechanistic investigations of phosphoroimidazolide
reactions